NCT01377428View on ClinicalTrials.gov

Efficacy of Indacaterol 150 µg Versus Formoterol

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Indacaterol

Indacaterol 150 µg once daily (od) via single-dose dry powder inhaler (SDDPI)

DRUG

Formoterol

Formoterol 12 µg twice daily (bid) via single-dose dry powder inhaler (SDDPI)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY